Tissue Bioavailability
Tissue Bioavailability is a pharmacokinetic construct that denotes the extent and rate at which an administered drug reaches a specific target tissue in a biologically active form, distinguishing it from systemic bioavailability by emphasizing localized tissue exposure rather than general circulation.
277
Publications
14.5K
Citations
1.6K
Authors
508
Institutions
Publications per year
2017–2026
82
Parents
277
Exosomes for the Enhanced Tissue Bioavailability and Efficacy of Curcumin
Farrukh Aqil, Radha Munagala, Jeyaprakash Jeyabalan et al. · The AAPS Journal · 2017 · 300 citations
Pharmacy, Cell Biology, Pharmacology +12
1–5 of 277
1.6K
3
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 1.6K
508
University of Illinois Urbana-Champaign
Urbana, United States
5 h-index
17 publications
757 citations

The University of Queensland
Brisbane, Australia
4 h-index
11 publications
859 citations

Chinese Academy of Sciences
Beijing, China
4 h-index
22 publications
495 citations
Shenyang Pharmaceutical University
Shenyang, China
4 h-index
24 publications
3.1K citations

University of Georgia
Athens, United States
4 h-index
9 publications
910 citations
University of Wisconsin–Madison
Madison, United States
4 h-index
6 publications
259 citations
University of Florida
Gainesville, United States
3 h-index
16 publications
1K citations

University of Alberta
Edmonton, Canada
3 h-index
7 publications
161 citations
1–8 of 508
11 publications · 932 citations
11
h-index
Repository · 10 publications · 433 citations
10
h-index
8 publications · 451 citations
8
h-index
7 publications · 520 citations
7
h-index
5 publications · 244 citations
6
h-index
1–5